In orthopaedic medicine, connective tissues are often affected by traumatic or degenerative injuries, and surgical intervention is required. Rotator cuff tears are a common cause of shoulder pain and disability among adults. The development of graft materials for bridging the gap between tendon and bone after chronic rotator cuff tears is essentially required. The limiting factor for the clinical success of a tissue engineering construct is a fast and complete vascularization of the construct. Otherwise, immigrating cells are not able to survive for a longer period of time, resulting in the failure of the graft material. The femur chamber allows the observation of microhaemodynamic parameters inside implants located in close vicinity to the femur in repeated measurements in vivo. We compared a porous polymer patch (a commercially available porous polyurethane-based scaffold from Biomerix™) with electrospun polycaprolactone (PCL) fibre mats and chitosan (CS)-graft-PCL modified electrospun PCL (CS-g-PCL) fibre mats in vivo. By means of intravital fluorescence microscopy, microhaemodynamic parameters were analysed repetitively over 20 days at intervals of 3 to 4 days. CS-g-PCL modified fibre mats showed a significantly increased vascularization at Day 10 compared with Day 6 and at Day 14 compared with the porous polymer patch and the unmodified PCL fibre mats at the same day. These results could be verified by histology. In conclusion, a clear improvement in terms of vascularization and biocompatibility is achieved by graft-copolymer modification compared with the unmodified material.
| INTRODUCTION
In orthopaedic medicine, connective tissues are often affected by traumatic or degenerative injuries, and surgical intervention is required. Rotator cuff tears are a common cause of shoulder pain and disability among adults. The aetiopathogenesis of rotator cuff tears is not resolved finally. Several theories concerning the reasons of rotator cuff tears distinguishing between extrinsic and intrinsic factors were discussed in Giai Via, De Cupis, Spoliti, and Oliva (2013) . In addition to the unknown aetiopathogenesis of rotator cuff tears, the healing process in tendon-to-bone interfaces is very slow because of low vascularization in tendon tissue. Thereby, the nutrition and the removal of inflammatory products are impeded. At the present time, several strategies for the management of rotator cuff injuries are discussed, but numerous attempts to rebuild the transition zone and to restore a functional enthesis have been shown to be unsuccessful (Boileau et al., 2005; Jost, Zumstein, Pfirrmann, & Gerber, 2006) . The structure of the transition zone between tendon and bone, called enthesis, is mechanically and biologically complex. The importance of this structure arises from its function. The attachment of two dissimilar materials results in stress singularities at their interface. The transitional tissue of the enthesis that shows structural and compositional gradients reduces stress concentrations and warrants an optimal transmission of forces between the stiff, brittle bone, and the tough, extensible tendon (Zelzer, Blitz, Killian, & Thomopoulos, 2014; Lu & Thomopoulos, 2013) . The fibrocartilaginous enthesis in the rotator cuff is classified in four distinct zones of tissue with a structurally continuous gradient from uncalcified tendon to uncalcified fibrocartilage to calcified fibrocartilage to calcified bone. The junctions between distinct tissue types are prone to injury, and unfortunately, their recovery following surgical repair is only poor. Injuries are more frequent in fibrocartilaginous enthesis than in fibrous insertions (Apostolakos et al., 2014) .
During the early healing process, the tendon-to-bone junction is not resilient, because the complex tendon-to-bone-construct is replaced by fibrotic tissue. After months and weeks, the biomechanical strength increases due to the remodelling process at the tendon-tobone junction (Gulotta, Kovacevic, Packer, Deng, & Rodeo, 2011) .
However, the healing process results solely in a repair of the damaged junction, thus leading to the formation of scar tissue and not in the regeneration of the naturally occurring tendon-to-bone interface with its organized distinct composition of four zones (Rodeo, 2007) .
In case of a chronic rotator cuff tear, the typically long latency between occurrence, diagnosis, and treatment leads to chronic changes in the musculotendinous unit. Muscle atrophy and fatty infiltrations of the muscle arise through the loss of muscle activity and the loss of pretension (Gerber, Meyer, Schneeberger, Hoppeler, & Von Rechenberg, 2004; Gerber et al., 2009) . Consecutively, the tendon retracts, and surgical repair is complicated (Meyer, Wieser, Farshad, & Gerber, 2012) . To accomplish surgical tendon repair, the gap between bone and tendon must be bridged by applying tension to extend the tendon, or the gap has to be closed by augmentation with a graft (Meyer, Gerber, von Rechenberg, Wirth, & Farshad, 2011) . All implantations lead to an inflammatory response either because of the surgical trauma or as a reaction to the implant itself. The inflammatory response is based on the well-known foreign body reaction depending on the material and its surface characteristics. To reduce this reaction, implants can be modified with coatings or used as carriers for medication and growth factors (Ferracini et al., 2018) . The used materials must be biocompatible to prevent adverse immunological reaction. Additionally, the structure of implants is of great importance for cells to attach, proliferate, and migrate. The survival of the implant and thus the success of the therapy after implant placement are dependent on the migration of the cells and their supply with oxygen and nutrients as well as the removal of waste (Lovett, Lee, Edwards, & Kaplan, 2009 ). Therefore, the key factor is adequate angiogenesis, especially in the early stages after implantation. Previous in vivo investigations of angiogenic processes after the application of implants were carried out mostly in soft tissue models, such as the dorsal skinfold chamber (Rücker et al., 2006) . Recently, different hard tissue models like the cranial window have been described (Sinikovic et al., 2011) . With respect to orthopaedic applications, the examination of implants in the area of long tubular bones is more appropriate.
The femur chamber model in mice allows the assessment of the microcirculation in a femoral defect model in immediate vicinity of the bone . In this study, we adapted this model to allow the application in rats without a bone defect. Therewith, information about angiogenesis can be given in the target area of orthopaedic implants.
Implants, which are not intended to remain permanently in the body and difficult to remove after healing, should be biodegradable without toxic remains. The rate of degradation should correspond to the rate of tissue restoration. The physiological situation at the defect site should be restored by invading cells in the long term whereas the implant is transformed into harmless degradation products that can be metabolized.
In line with these arguments, polycaprolactone (PCL) is used in various biomedical applications because of its biocompatibility, adequate mechanical properties, and slow degradation in vivo (Lam, Hutmacher, Schantz, Woodruff, & Teoh, 2008; Dash & Konkimalla, 2012) . PCL can be processed by electrospinning, which allows a controlled design of fibre alignment, porosity, fibre diameter, and pore size (Font Tellado, Balmayor, & Griensven, 2015) . Although PCL is biocompatible, its surface is hydrophobic and thus not particularly attractive for cell attachment and growth (Venugopal, Ma, Yong, & Ramakrishna, 2005) . Therefore, PCL is unattractive for biomedical applications (Nair & Laurencin, 2007) . Furthermore, because PCL is an aliphatic polyester, it lacks access to easy modifications, and chemically more reactive moieties have to be introduced by various approaches such as plasma or wet chemical treatment, blending, and attachment of graft copolymers (Fu, Sammons, Bertóti, Jenkins, & Dong, 2011; Tallawi et al., 2015; de Cassan et al., 2018) . These modifications can help overcome these weaknesses of PCL, while maintaining good properties, and create implants applicable in a variety of orthopaedic areas, for example, the use in therapy of chronic rotator cuff tears.
Therefore, the purpose of this study is to characterize the vascularization and biocompatibility of PCL-based implants in the hard tissue model of femur chamber in rats, in comparison with commercially available implant material.
| MATERIALS AND METHODS

| Implants
For the experimental groups, electrospun fibre mats were produced by electrospinning of poly-ε-caprolactone (M n = 80,000, Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany; PCL) and trifluoroethanol (abcr As a second experimental group, the same PCL fibre mats were additionally modified with chitosan, called chitosan-g-PCL. For synthesis, chitosan-PCL graft copolymers were crystallized on PCL nanofibres, as described recently (de Cassan et al., 2018) . Thereby, chitosan is presented at the surface of the fibre.
As a control group, a commercially available porous polymer scaffold (Biomerix RCR Patch, Biomerix Corporation, Somerset, USA; purchased from Cellon, Bascharage, Luxembourg; Encalada-Diaz et al., 2011) was used. This biocompatible scaffold has an interconnected 3D network of pores with a pore size of 100 to 250 μm. The material is designed to mimic the nature and function of the extracellular matrix for regenerative medicine research (Encalada-Diaz et al., 2011) . For further characterization, scaffolds of each group were stamped with a circular cutter to a diameter of 15 (mass analysis) and 25 mm (porosity). In the case of fibre mats, material for the implants as well as for the further characterization is obtained from the middle area. In this area, the structure of the fibre mats is more homogeneous than in the peripheral areas.
For in vivo experiments, scaffolds of each group were cut into pieces of 3 × 5 mm and shrink-wrapped in sterilization pouches (SteriClin, Vereinigte Papierwarenfabriken, Feuchtwangen, Germany).
The sterilization was performed by beta radiation with a dose of 25 kGy (using a Rhodotron TT 100 e-beam accelerator, Mediscan, Kremsmünster, Austria).
| Evaluation of porosity and pore diameter
The porosity of the fibrous scaffolds was determined by the gravimetric method. This method uses the mass, density, and dimensions of a sample to calculate the porosity (equation below).
with porosity Φ, empty volume V E in cm 3 , total volume V T in cm 3 , mass m in g, polymeric density ρ in g/cm 3 , sample thickness s in cm, and sample diameter d in cm.
The sample mass was determined with a high-precision scale. For determination of the thickness, the sample was cut in half in liquid nitrogen with a razor blade. Images of the cutting edge were taken with a scanning electron microscope (SEM, Hitachi S-3400) and
analysed with an image analysis software (AxioVision, Carl Zeiss).
The pore diameter was determined with a capillary flow porometer (3 Gzh, Quantachrome GmbH & Co.KG). Porofil® (Quantachrome GmbH & Co.KG) was used as wetting liquid to spontaneous fill all pores in the sample. The solid-gas interface was thereby replaced by a solid-liquid interface. Pressure from a non-reactant gas was gradually increased on the top side of the sample. When the energy of the non-reactant gas exceeds the interfacial free energy of the solid/liquid interface, Porofil® was replaced by the non-reactant gas.
Gas flow occurs through the largest pore of the sample (Jena & Gupta, 2001 ). Further pressure increase emptied smaller pores.
The software 3Gwin (Quantachrome GmbH & Co.KG) detected the flow rate over the pressure. A wet (liquid-filled) curve and a dry (liquid-free) curve were measured for each sample. From the collected data, the pore diameter was calculated by the software using following equation:
Where D is the pore diameter, γ the surface tension of the wetting liquid, θ the contact angle of the wetting liquid, and p the differential pressure (Li, Frey, & Joo, 2006) .
| Experimental protocol
Twenty-six Lewis/Han Ztm rats were equipped with femur chambers.
Scaffolds consisting of either a porous polymer patch (control; n = 8) or unmodified PCL fibre mats (PCL; n = 9) or chitosan (CS)-graft-PCL modified electrospun PCL fibre mats (CS-g-PCL; n = 9) were implanted. Intravital fluorescence microscopy (IVM) analysis of volumetric blood flow, wall shear rate, leukocyte-endothelial cell interaction, macromolecular leakage, and functional capillary density were performed immediately as well as 3, 6, 10, 14, 17, and 20 days after implantation.
| Animals
All experiments were conducted in accordance with the German legislation for the protection of animals and the Guide for the Care and . Male Lewis rats with a body weight of 383 ± 65 g were used for the study with an age of 27 ± 12 weeks. All animals were housed individually per cage at room temperature between 22°C and 24°C and a relative humidity of 60-65% with a 12-hr day-night cycle. The rats had free access to tap water and standard pellet food (1328 Hybridpellet, Altromin, Lage/Westphalia, Germany) at all times.
| Anaesthesia
The preparation of the femur chamber and repeated IVM was executed under inhalational anaesthesia (EZ-7000 Classic System, PLEXX, Elst/The Netherlands) by isoflurane. The animals were placed in an induction chamber, and anaesthesia was induced with 5% isoflurane (isoflurane, Isofluran CP®, 1 ml/ml, cp pharma, Burgdorf, Germany) until loss of righting reflex. The anaesthesia depth was determined with the aid of the toe pinch. After induction, the animals were placed in lateral position on a heating mat to protect the animals against hypothermia. Animals remained anaesthetized with the aid of a nose cone with 2-3% isoflurane in oxygen.
| Preparation of the rat femur chamber
The animals received a pain medication including butorphanol (butorphanol, 0.05 mg/kg, Torbugesic 10 mg/ml, cp pharma, Burgdorf, Germany) and carprofen (carprofen, 5 mg/kg, Carprosol 50 mg/ml, cp pharma, Burgdorf, Germany) preoperatively. After shaving, depilating and disinfection of the left hind limb, the skin was cut over the length of the femur, and the musculature in this field was carefully separated to expose the femur. As local anaesthesia lidocaine (lidocaine, 5 mg/kg, Lidocainhydrochlorid 2%, bela-pharm, Vechta, Germany) was applied directly on the femur before fixation of the chamber frame (see Figure 1 for details of the chamber design) and the trochanter major was removed using a dental burr (Komet dental, Gebr. Brasseler GmbH Medical GmbH, Ethicon Deutschland, Norderstedt, Germany). To protect the cover glass against manipulation by the rats, the observation window was covered with a lid, which was fixed by two screws. The rats were treated with antibiotics (enrofloxacin 5 mg/kg, Baytril 25 mg/ml, Bayer, Leverkusen, Germany) intraoperatively and per os for 7 days and with analgetics (carprofen, 5 mg/kg, Rimadyl 50 mg/ml, Pfizer Deutschland GmbH, Berlin) for 2 days after surgery.
Postoperatively, the animals were given 3 days for convalescence and adaption to the femur chamber before insertion of the implant material. For implantation, the lid, the coverslip, and the cover glass were removed. In anaesthesia, the implant material was inserted in the centre of the observation window and fixed with the suture material, which had been placed around the femur during operation. For this purpose, the suture material is knotted over the implant. During the experimental period, the animals were evaluated daily with a scorebased evaluation system including the assessment weight loss, general condition, spontaneous behaviour, clinical findings, and lameness.
| Intravital fluorescence microscopy
For intravital microscopic observation of the microcirculation, the animals were anaesthetized as described above, and the left hind limb was immobilized by a custom-made restraint device. Animals received an intravenous injection in the tail vein of 0. 
| Analysis of microcirculatory parameters
The recorded data were analysed by means of the image analysis software CapImage (CapImage 8.6.3., Zeintl, Heidelberg Germany). Klyscz, 1997) . Volumetric blood flow was calculated by
For correction of the parabolic velocity profile in microvessels, the Baker-Wayland factor 1.6 was used (Baker & Wayland, 1974) . Based on the Newtonian definition, the wall shear rate was calculated by y ¼ 8 × v d . Macromolecular leakage was analysed by means of grey levels in the tissue directly adjacent to the venular vessel wall (E 1 ) and in the marginal cell free plasma layer within the blood vessel (E 2 ). Extravasation (E) was calculated as E = E 1 /E 2 . Microvessel density, defined as the length of blood vessels per area of observation given in cm/cm 2 , was measured in the periphery around the implant and in the centre of the implant. Both values were displayed as the total functional capillary density expressed as the sum of peripheral and central functional capillary density.
| Histology and immunohistochemistry
At the end of the postoperative observation period of 20 days, animals were finalized via cervical dislocation under deep anaesthesia, and histological examinations were performed. Formalin-fixed specimens of the femur were embedded in Technovit 9100 (Willbold & Witte, 2010 
| Statistics
Results are expressed as means ± standard error of the mean (SEM).
Differences between groups were assessed by one-way analysis of variance (ANOVA), and differences within groups were analysed by one-way repeated measures ANOVA. To isolate differences between pairs of groups, Student-Newman-Keuls post hoc tests were performed. Differences were considered significant at p < .05.
3 | RESULTS
| Properties of the material
The control group (porous polymer patch) showed very large pore sizes of up to 175.34 μm and a high porosity (Table 1) . Produced PCL fibre mats show a non-aligned structure as it can be seen in SEM images (Figure 2 ). It was found that the pure PCL had a porosity of 80.61%. The maximum pore size (9.19 μm) was considerably lower than for the control group (Table 1) . Modification with the graftcopolymer CS-g-PCL reduced the porosity to 76.21% and simultaneously increased the fibre diameter (Table 1 ). This observation was to be expected when applying a surface coating by crystallization to the electrospun PCL fibres.
| Animals
The animals showed no signs of discomfort or changes in behaviour.
Immediately after anaesthesia, the operated limbs were loaded again.
In the control group 1, animal was lost because of weight loss. In the PCL group 1, animal was lost because of failure of chamber fixation.
In the CS-g-PCL group 3, animals were lost because of anaesthesia and weight loss. These animals were not included in the statistical evaluation.
| Microhaemodynamic parameters
First, immediately after implantation and on Day 3, microhaemodynamic parameters were not detectable by means of IVM. The collected data including the diameter, the volumetric blood flow, and the wall shear rate indicated that the different implant materials interfered with the microvascular blood flow of host tissue.
Venular diameters stayed constant in all experimental groups ranging between 14 and 19 μm (Table 2) . Volumetric blood flow and wall shear rates of venules were not significantly altered (Table 2) .
| Functional capillary density
Immediately 
| Histology and immunohistochemistry
Haematoxylin-eosin-staining showed obvious differences in cell infiltration depending on the implant material. Infiltration with cells appeared uniform in the control group. In the PCL group, however, ingrowth of cells was also detectable, but to a lesser extent compared with the control group. The PCL group showed a clear cellular margin with a kind of encapsulation (Figure 5e ). In the CS-g-PCL group, the histological findings were comparable, but there was barely no margin around the implant present (Figure 5a-f) .
Collagen fibres were visualized by van Gieson staining (Figure 5g-i) .
Collagen fibres were histologically representable in the control group as well as in the experimental groups. The control group showed an equal distribution of orientated collagen fibres around the implant structure.
The PCL group showed collagen fibres especially in the border area of the implant, which were less prominent compared with the control group. In the CS-g-PCL group, only a few collagen fibres around the implant could be demonstrated.
A semiquantitative analysis of foreign body giant cells (FBGC; Figure S1 ) revealed the highest number of FBGC around the unmodified PCL implants. In the control group and the CS-G-PCL group, the count of FBGC was comparably low. 
| DISCUSSION
In this study, using the femur chamber in rats, we demonstrated that CS-g-PCL modification of PCL fibre mats improved angiogenesis in vivo. Currently, tissue regeneration after defects independent of the field of application is limited by the absence of proven strategies for the generation of adequately vascularized tissues . Sufficient perfusion is important for oxygen supply, nutrition of cells and tissues when cellular ingrowth in scaffolds shall be achieved, and for removal of metabolites (Lovett et al., 2009 ). Therefore, it is of great importance to gather knowledge about the extent and time course of vascularization of different implant materials before they can be successfully used in a clinical setting .
The modification of the PCL fibre mats with CS-g-PCL showed a marked improvement in angiogenesis in the first 2 weeks after TABLE 2 Venular diameters in μm, volumetric blood flow in pl/s, and wall shear rate in s −1 of postcapillary and collecting venules at the border zones of the porous polymer patch control group (control), the unmodified PCL fibre mat group (PCL), and the chitosan-modified PCL fibre mat group (CS-g-PCL) 6, 10, 14, 17, and 20 days after implantation implantation compared with the unmodified mats and the control group. Particularly in the early phase, rapid development of vessels for supply of ingrowing cells is important. Only then the survival of the immigrant cells and thus the survival of the implant secured. Vessels were detected at Day 6 onwards in this model although angiogenesis was expected to start sooner (Carmeliet, 2000; Ke & Costa, 2006) .
Studies in the dorsal skinfold chamber in mice and hamsters showed that angiogenesis already had increased on Day 3 (Zimmerer et al., 2017) . Whereas in the femur chamber in mice, which is a hard tissue model and therefore maybe the better comparison, results on angiogenesis were also obtained from Day 6 . Angiogenesis is the complex and tightly regulated process of formation of new capillaries from existing blood vessels . After an injury, acute necrosis and hypoxia occur in the affected area. The local oxygen concentration regulates the expression of the angiogenic factor VEGF via hypoxia-inducible factor-1α Norrby, 1997) . A reason for the finding that we could observe first signs of angiogenesis beginning from Day 6 might be the surgical results later in the formation of a structured network of vessels (Carmeliet, 2000) . By determining the functional capillary density in the length of the vessels per area, this results in a smaller value. Many small vessels were measured by Day 14. By remodelling the intravital microscopic examination showed fewer but larger vessels.
Modification of PCL with chitosan is often used to enhance biocompatibility of PCL-based scaffolds for different tissue engineering approaches. This can be achieved either by first modifying the polymers and generating scaffolds via electrospinning as a consecutive step (Chen, Huang, Yu, Liu, & Gu, 2011) or, as with the CS-g-PCL scaffold in this study, as a secondary modification after electrospinning of PCL. This modification resulted in an increased in vitro biocompatibility in terms of enhanced cell attachment and growth compared with uncoated PCL fibre mats (de Cassan et al., 2018) . In the present study, these data were supported by our in vivo data in reference to biocompatibility and angiogenesis. In contrast to the PCL group, which showed a prominent fibrous capsule, the CS-g-PCL group showed only a minor deposition of collagen fibres around the implant and the lowest amount of FBGC proofing the good biocompatibility achieved by the chitosan modification. The number of FBGC was comparable in the control group, but there was a higher deposition collagen with orientated fibres, which may be a hint of a stronger foreign body reaction. With respect to the short observation period after implantation, this is just a hypothetical assumption, which should be proven in further studies.
Although we could show an enhanced angiogenesis as a reaction to the implantation of PCL-based scaffolds, there is still a lack of vessels inside the PCL-based scaffolds. Only in the CS-g-PCL group vessels were detectable inside the scaffold. A crucial factor for the vascularization of implants and the ingrowth of cells is the porosity of the implant. In a study using the mice skinfold chamber model and intravital microscopy, a pore size of approximately 250-300 μm was found to promote the best vascularization of poly(ether ester)
block-copolymer scaffolds (Druecke et al., 2004) . In this study, the authors also showed that the effect of pore size is more prominent in the centre of the implant. Implants with a larger pore size showed a higher functional capillary density in the border zone at early time points, but later, there was no difference between the different pore sizes observable. This effect is also present in our study: At later time points, the functional capillary density is comparable in all groups in the border zone of the implants. At the centre of the implants, we observed differences between the groups also at later time points.
Taking the development of the granulation tissue into account, this result can be explained. We assume that development of the granulation tissue originated from the tissue underneath the implants resulting in a faster growth in the border zone of the implants.
Because of the larger pore size, tissue growth through the pores of the implants was only observed to a larger extent in the control group.
In the CS-g-PCL group, we detected a limited ingrowth of capillaries, whereas we detected no vascular ingrowth into the implants of the PCL group. From this observation, one would assume that the functional capillary density in the centre will reach the highest value in the control group, but our results showed that functional density in the centre reached the highest values in the CS-g-PCL group. This finding reflects the good biocompatibility of these implants accomplished by the chitosan modification and may be due to an accelerated growth of granulation tissue that rapidly enwrapped the implant. Further developments of the CS-PCL scaffolds may be needed to further enhance the ingrowth of vessels. To achieve this aim, various approaches are possible. One possibility is the addition of angiogenic growth factors, which trigger vessel growth. Release of VEGF from porous PCL-based scaffolds caused an enhancement of angiogenesis, which led to a higher ingrowth of vessels into depth of the scaffold (Singh, Wu, & Dunn, 2012) , and more mechanistic approaches are possible. Vascularization of scaffolds depends to a large extend on the accessibility of the inner parts of the scaffold for growing vessels. With respect to electrospun scaffolds, an increase in pore size can be achieved via the inclusion of sacrificial fibres of a water soluble polymer during the spinning process (Phipps, Clem, Grunda, Clines, & Bellis, 2012) . These fibres were removed after production of the scaffold leading to a larger mean pore size, which in turn facilitates the ingrowth of cells. Larger pores can be generated by means of laser cutting. Increasing diameters of pores enhanced the vascularization of scaffolds and in turn resulted in a better cellular infiltration (Joshi, Lei, Walthers, Wu, & Dunn, 2013) . This effect is also influenced by the overall porosity. The higher the content of macropores was, the more blood vessels inside the scaffold and infiltrating cells could be detected (Walthers, Nazemi, Patel, Wu, & Dunn, 2014) . With regard to our study, we assume that a further enhancement of angiogenesis and particularly of cell infiltration into the CS-g-PCL scaffold could be induced by enhancing the porosity and pore size of the scaffold.
This could be achieved via the generation of macropores or by using larger fibre diameters, which in turn also will result in enhanced mechanical properties of the scaffolds, as was shown by Wang et al. (2014) .
Different models for assessing the angiogenic and inflammatory reaction after the implantation of different materials have been established so far. Most of these models are performed using mice (Burghartz et al., 2015) or rats (Seyednejad et al., 2012) and are characterized by a final point at which the samples are examined. However, these end point models cannot generate any information regarding the changes in the vasculature over the time course of the experiment. To explore the angiogenic and inflammatory reaction of soft tissues, the dorsal skinfold chamber is a widely used model (Kampmann et al., 2013) . As a comparable model for the investigation of vascularization and biocompatibility in hard tissues, the femur chamber in mice, which allowed to place implants in the immediate environment of the femur, was established . In the present study, we used a model, which was adapted to the femur of rats. In contrast to the mouse femur chamber in the rat model, no bone defect was created. Instead, the implant was fixed by means of suture material to the bone. The area in which the trochanter major was removed is only for fixation of the chamber and is not in the observation window. There was no bone defect in the observation area in the bone. This preparation method may have affected the measured parameters, as the periosteum may be injured by manipulation during surgery. Nevertheless, the results provide important information about vascularization of implants in bony environment, because even in patients, the periosteum may already be injured by rupture of the tendon or is damaged during surgical procedure. The femur chamber was characterized by an observation chamber, which permitted a steady microscopic view of the implanted scaffold without disturbance of the growing tissue and therefore the study of the hard tissue reaction repeatedly in the same animal over an evaluation period of 20 days. Furthermore, by recording leucocyte endothelial interactions, we could also generate data about the local inflammatory response to the scaffold implantation, which is also not possible with standard end point models.
As a control group, a commercial porous polymer patch was used, which has a proven biocompatibility. Despite the fact that the material parameters of the control group markedly differ from experimental groups, this material was chosen, because earlier studies confirmed the improvement of mechanical properties using this patch for rotator cuff tear repair (Ricchetti, Aurora, Iannotti, & Derwin, 2012). In the experimental groups, PCL, which is well known for its biocompatibility, was used to fabricate electrospun fibre mats. During electrospinning, undirected fibres were produced mimicking the structure of unaligned collagen fibres of the bone. In addition, the process of electrospinning increased the mechanical stability, because unprocessed PCL is not sufficient for load bearing applications (Agrawal & Ray, 2001 ).
In conclusion, graft copolymer modification showed improved vascularization compared with the unmodified material. The approach of this study is promising for clinical use of CS-g-PCL-based implants in various clinical applications, after further examination of the CS-g-PCL implants in small and large animals.
